And I do have several favorite stocks that fit that description. My top growth stock to buy in November is one that I've ...

Good morning, everyone. My name is Dina Elmonshed, one of the U.S. biotech analysts here at UBS. And joining me today is the President and CEO of Vertex Pharmaceuticals, Reshma Kewalramani. Thank you ...

The stock of niche financial software company Vertex ( VERX 4.13%) didn't get a very good start to the trading week at all. Its value fell by nearly 10% that day, due largely to a quarterly earnings ...

V2X, Inc. (NYSE:VVX) ("V2X"), a leading provider of global mission solutions, announced today the sale of 2.25 million shares ...

Google has offered several ways of generating and modifying code with Gemini models, but the launch of Gemini 3 adds a new ...

The first wave of Commissioner’s National Priority Vouchers signals a fundamental shift in FDA competitiveness, rewarding companies that pair breakthrough science with affordability commitments, ...

Gemini 3 excels at coding, agentic workflows, and complex zero-shot tasks, while Antigravity shifts AI-assisted coding from ...

Google calls Gemini 3 "the best model in the world for multimodal understanding," and it's widely rolling out in preview.

Google Cloud has rolled out a series of updates to its Vertex AI Agent Builder in the hope that developers continue to build, test and deploy AI agents on its platform, with an emphasis on faster ...

After more than a month of rumors and feverish speculation — including Polymarket wagering on the release date — Google today ...

EXCLUSIVE: The Express has campaigned for cystic fibrosis sufferers for six years but now a charity is highlighting the CF symptoms no-one talks about.